Director & Lead Investor
2017 - Present
Byron has served as the lead investor and sole independent director of ForeSee Medical, Inc. since its formation in 2017. ForeSee is a successor company that was funded in 2017 by the same team which founded and successfully exited from Health Fusion by a sale in 2016 to NextGen (www.nextgen.com). Byron and his family were lead investors in Health Fusion and committed a portion of their gains from Health Fusion to become lead investors in ForeSee Medical.
ForeSee ESP risk adjustment software works where you need it, at the point of care. Our disease detection algorithms and machine learned natural language processing rationalize patient data across the healthcare system. It's simple, using artificial intelligence (AI) to discover diseases from text notes and EHR data. Then, we empower you with insightful HCC risk adjustment support integrated seamlessly with your electronic health records.